Here's an example of TB2's blue sky. Just bought by Astellas for US$3bn - AUD$4.5bn.
Whilst its a decent overreach comparing to PYCtx today perhaps in 2 years time...
The only place PYCtx should be targeting being right now is the US. If you look at the Audentestx website you'll find lots of brokers. They have the expertise up there to see value in these kinds of coys.
https://www.businesswire.com/news/home/20191202005969/en/Astellas-Enters-Definitive-Agreement-Acquire-Audentes-Therapeutics
https://www.audentestx.com/innovative-therapies/
Ann: Drug Delivery Greater Than 100% More Effective In Animals, page-30
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.005(0.42%) |
Mkt cap ! $702.8M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.23 | $1.20 | $412.4K | 342.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 512674 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 62126 | 4 |
View Market Depth
| Last trade - 11.12am 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |